VAXNEUVANCE 30 ug/.5mL
Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed · INJECTION, SUSPENSION · Merck Sharp & Dohme LLC
Vaxneuvance is a pneumococcal vaccine injection that helps protect against 15 types of pneumococcal bacteria that can cause serious infections like pneumonia and meningitis. It is available over-the-counter and is given as an intramuscular injection.
Key Facts
- Brand Name
- VAXNEUVANCE
- Generic Name
- Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed
- NDC Code (Product)
0006-4329- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 30 ug/.5mL
- Dosage Form
- INJECTION, SUSPENSION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125741
- Marketing Start
- 07/16/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is VAXNEUVANCE used for?
Vaxneuvance is a pneumococcal vaccine injection that helps protect against 15 types of pneumococcal bacteria that can cause serious infections like pneumonia and meningitis. It is available over-the-counter and is given as an intramuscular injection.
Is VAXNEUVANCE a controlled substance?
VAXNEUVANCE is not classified as a controlled substance by the DEA.
What is the generic name for VAXNEUVANCE?
The generic name for VAXNEUVANCE is Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed. There are no other listed brand versions of Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed.
What is the NDC code for VAXNEUVANCE 30 ug/.5mL?
The NDC (National Drug Code) for VAXNEUVANCE 30 ug/.5mL is 0006-4329, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)